CCP Score Stratifies Risk for Prostate Cancer Patients at Biopsy: Initial Commercial Results

E. David Crawford(University of Colorado Denver), Neal D. Shore(Carolina Urologic Research Center), Peter T. Scardino(Memorial Sloan Kettering Cancer Center), John W. Davis(The University of Texas MD Anderson Cancer Center), Jonathan D. Tward(Huntsman Cancer Institute), K. Moyes(Myriad Genetics), L.M. Fitzgerald(Myriad Genetics), Steven Stone(Myriad (Germany)), M K Brawer(Myriad Genetics)
International Journal of Radiation Oncology*Biology*Physics
September 1, 2014
Cited by 0Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis